|
Sign In to gain access to subscriptions and/or personal tools.
|
Factor V Leiden Mutation in Venous Thrombosis in Southeast Turkey
Sevgi Kalkanli, PhD
Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey, sgkalkanli{at}yahoo.com
Orhan Ayyildiz, MD
Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey
Naci Tiftik, MD
Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey
Sabri Batun, PhD
Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey
Abdurrahman Isikdogan, MD
Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey
Hakan Ince, PhD
Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey
Selahaddin Tekes, PhD
Department of Medical Genetic-Biology, University of Dicle, Diyarbakir, Turkey
Ekrem Muftuoglu, MD
Department of Hematology-Oncology, University of Dicle, Diyarbakir, Turkey
Venous thrombosis (VT) is a common disease, with an annual incidence in the general population of approximately 1 per 1,000. Factor V Leiden mutation (G1691A) (FVL) is the most common risk factor in venous thrombosis. The prevalence of FVL for thrombosis varies greatly in different regions of the world. FVL mutation has been identified both by conventional method and fluorescence resonance energy transfer (FRET) with the LightCycler. Sixty-one patients with VT, different in age and sex, were consecutively entered into this study to assess the prevalence of FVL in VT in southeast Turkey. FVL mutation was found in 24.6% (15/61). Fourteen individuals were heterozygous and 1 homozygous, a rate of 22.9% and 1.6%, respectively. In conclusion, the authors suggest that FVL mutation is common in patients with venous thrombosis in southeast Turkey.
References
- Rosendaal FR: Risk factors for venous thrombotic disease. Thromb Haemost 82:610-619, 1999.[Web of Science][Medline]
[Order article via Infotrieve]
- Poort SR, Rosendaal FR, Reitsma PH, et al: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.[Abstract/Free Full Text]
- Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008, 1993.[Abstract/Free Full Text]
- Griffin JH, Evatt B, Wideman C, et al: Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993, 1993.[Abstract/Free Full Text]
- Rosendaal FR, Koster T, Vandenbroucke JP, et al: High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 85:1504-1508, 1995.[Abstract/Free Full Text]
- Hagstrom JN, Walter J, Langner RB, et al: Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 133:771-781, 1998.
- Bertina RM, Koeleman BPC, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.[CrossRef][Medline]
[Order article via Infotrieve]
- Gregg JP, Yamane AJ, Grody WW: Prevalence of the factor V Leiden mutations in four distinct American ethnic populations. Am J Med Gen 73:334-336, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ozbek U, Tangun Y: Frequency of factor V Leiden in Turkey. Int J Hematol 64:291-292, 1996.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 346:1133-1134, 1995.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Koster T, Rosendaal FR, de Ronde H, et al: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506, 1993.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lay MJ, Wittwer CT: Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chemist 43:2262-2267, 1997.
- Ridker PM, Hennekens CH, Lindpaintner K, et al: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912-917, 1995.[Abstract/Free Full Text]
- Ridker PM, Miletich JP, Hennekens CH, et al: Ethnic distribution of factor V Leiden in 4,047 men and women. JAMA 277:1305-1307, 1997.[Abstract/Free Full Text]
- Chaa WP, Lee CK, Kwong YL, et al: A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91:1135-1139, 1998.[Abstract/Free Full Text]
- Gurgey A, Haznedaroglu IC, Egesel T, et al: Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol 67:107-111, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kalkanli S, Ayyildiz O, Tiftik N, et al: Factor V Leiden mutation in our region. XIX. National Gevher Nesibe Meeting, Congress and Workshop of Hematology-Oncology, Congress Book (Turkish). Nevsehir, Turkey, May 24-26, 2001, pp 106-106.
Angiology, Vol. 57, No. 2,
193-196 (2006)
DOI: 10.1177/000331970605700209
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
